Low Vitamin D Status and 10-Year Dementia Risk in Sensory-Impaired Adults: A Propensity Score-Matched Cohort Study

Why It Matters

If low vitamin D is a modifiable factor, screening and supplementation could become part of dementia prevention strategies for sensory‑impaired seniors, a rapidly growing high‑risk population. The findings also highlight a potential target for public‑health interventions aimed at reducing the growing dementia burden.

Key Takeaways

• Vitamin D deficiency raises dementia risk 55% in sensory-impaired adults
• Hazard ratio for vascular dementia 1.70 with deficiency
• Osteoporotic fracture risk also increased, confirming exposure validity
• Detection bias unlikely; healthcare visits slightly lower in deficient group
• Insufficiency shows graded risk, HR 1.39 versus sufficiency

Pulse Analysis

Sensory impairment—particularly hearing loss—has been identified as one of the strongest modifiable contributors to cognitive decline, accounting for a sizable share of dementia cases worldwide. Parallel research suggests vitamin D influences neuroprotective pathways, including amyloid clearance and inflammation reduction. When these two risk factors intersect, older adults may experience compounded vulnerability, making the investigation of vitamin D status in this group both timely and clinically relevant.

The TriNetX‑based cohort leveraged more than 300,000 electronic health records, applying rigorous propensity‑score matching to balance demographics, comorbidities, and baseline supplement use. Vitamin D‑deficient participants exhibited a 55 % higher hazard of any dementia, with even steeper risks for vascular dementia (HR 1.70) and Alzheimer’s disease (HR 1.48). Although the absolute risk increase was modest—about 1.6 percentage points over ten years—the consistency across vision‑only, hearing‑only, and multiple subgroup analyses strengthens the signal. A concurrent rise in osteoporotic fractures served as a positive control, reinforcing the validity of the exposure classification.

From a practice standpoint, the study raises the prospect that routine vitamin D screening could be integrated into geriatric care for patients with sensory loss, potentially mitigating a portion of dementia incidence. However, residual confounding—such as unmeasured physical activity, socioeconomic status, or sunlight exposure—precludes causal inference. Randomized trials are needed to determine whether correcting deficiency translates into measurable cognitive benefits. Until then, clinicians should weigh the modest risk reduction against the safety profile of supplementation, especially in frail seniors, while policymakers consider targeted public‑health campaigns that address both sensory health and nutritional adequacy.